Alcohol withdrawal syndrome: diagnostic and therapeutic methods

Interdisciplinary Study Group CRARL - SITAC - SIPaD - SITD - SIPDip, Giovanni Laviola, Simone Macri, Rosanna Mancinelli

Research output: Contribution to journalReview article

Abstract

Alcohol withdrawal syndrome (AWS) is a medical emergency, rare in the general population, but very common among alcoholic individuals, which can lead to severe complications when unrecognized or late treated. It represents a clinical condition which can evolve in few hours or days following an abrupt cessation or reduction of alcohol intake and is characterized by hyperactivity of the autonomic nervous system resulting in the development of typical symptoms. According to DSM-5 criteria, the alcohol withdrawal syndrome is defined as such: if patients present at least two of typical signs and symptoms. The Clinical Institute Withdrawal Assessment of Alcohol Scale, revised version (CIWA-Ar), is the tool for assessing the severity of AWS. The support to patient with AWS includes pharmacological intervention as well as general support, restoration of biochemical imbalances and specific therapy. Regarding the pharmacological treatment, benzodiazepines represent the gold standard, in particular long-acting benzodiazepines, administered with a gradual reduction up to cessation.

Original languageEnglish
Pages (from-to)118-122
Number of pages5
JournalRivista di Psichiatria
Volume53
Issue number3
DOIs
Publication statusPublished - Jun 19 2018

Fingerprint

Alcohols
Benzodiazepines
Therapeutics
Pharmacology
Autonomic Nervous System
Signs and Symptoms
Emergencies
Population

Keywords

  • Alcohol Withdrawal Delirium/diagnosis
  • Alcohol Withdrawal Seizures/drug therapy
  • Alcoholism/blood
  • Anticonvulsants/therapeutic use
  • Antipsychotic Agents/adverse effects
  • Autonomic Nervous System/physiopathology
  • Benzodiazepines/administration & dosage
  • Combined Modality Therapy
  • Counseling
  • Delayed Diagnosis
  • Drug Therapy, Combination
  • Emergencies
  • Ethanol/adverse effects
  • Humans
  • Kindling, Neurologic
  • Palliative Care
  • Severity of Illness Index
  • Symptom Assessment
  • Thiamine/therapeutic use

Cite this

Alcohol withdrawal syndrome : diagnostic and therapeutic methods. / Interdisciplinary Study Group CRARL - SITAC - SIPaD - SITD - SIPDip ; Laviola, Giovanni; Macri, Simone; Mancinelli, Rosanna.

In: Rivista di Psichiatria, Vol. 53, No. 3, 19.06.2018, p. 118-122.

Research output: Contribution to journalReview article

Interdisciplinary Study Group CRARL - SITAC - SIPaD - SITD - SIPDip, Laviola, G, Macri, S & Mancinelli, R 2018, 'Alcohol withdrawal syndrome: diagnostic and therapeutic methods', Rivista di Psichiatria, vol. 53, no. 3, pp. 118-122. https://doi.org/10.1708/2925.29413
Interdisciplinary Study Group CRARL - SITAC - SIPaD - SITD - SIPDip ; Laviola, Giovanni ; Macri, Simone ; Mancinelli, Rosanna. / Alcohol withdrawal syndrome : diagnostic and therapeutic methods. In: Rivista di Psichiatria. 2018 ; Vol. 53, No. 3. pp. 118-122.
@article{f85e275b63b0486492dc039e7d5388dd,
title = "Alcohol withdrawal syndrome: diagnostic and therapeutic methods",
abstract = "Alcohol withdrawal syndrome (AWS) is a medical emergency, rare in the general population, but very common among alcoholic individuals, which can lead to severe complications when unrecognized or late treated. It represents a clinical condition which can evolve in few hours or days following an abrupt cessation or reduction of alcohol intake and is characterized by hyperactivity of the autonomic nervous system resulting in the development of typical symptoms. According to DSM-5 criteria, the alcohol withdrawal syndrome is defined as such: if patients present at least two of typical signs and symptoms. The Clinical Institute Withdrawal Assessment of Alcohol Scale, revised version (CIWA-Ar), is the tool for assessing the severity of AWS. The support to patient with AWS includes pharmacological intervention as well as general support, restoration of biochemical imbalances and specific therapy. Regarding the pharmacological treatment, benzodiazepines represent the gold standard, in particular long-acting benzodiazepines, administered with a gradual reduction up to cessation.",
keywords = "Alcohol Withdrawal Delirium/diagnosis, Alcohol Withdrawal Seizures/drug therapy, Alcoholism/blood, Anticonvulsants/therapeutic use, Antipsychotic Agents/adverse effects, Autonomic Nervous System/physiopathology, Benzodiazepines/administration & dosage, Combined Modality Therapy, Counseling, Delayed Diagnosis, Drug Therapy, Combination, Emergencies, Ethanol/adverse effects, Humans, Kindling, Neurologic, Palliative Care, Severity of Illness Index, Symptom Assessment, Thiamine/therapeutic use",
author = "{Interdisciplinary Study Group CRARL - SITAC - SIPaD - SITD - SIPDip} and Fabio Attilia and Roberta Perciballi and Claudia Rotondo and Ida Capriglione and Silvia Iannuzzi and Attilia, {Maria Luisa} and Giovanna Coriale and Mario Vitali and Federica Cereatti and Marco Fiore and Mauro Ceccanti and Giovanni Laviola and Simone Macri and Rosanna Mancinelli",
year = "2018",
month = "6",
day = "19",
doi = "10.1708/2925.29413",
language = "English",
volume = "53",
pages = "118--122",
journal = "Rivista di Psichiatria",
issn = "0035-6484",
publisher = "Il Pensiero Scientifico Editore s.r.l.",
number = "3",

}

TY - JOUR

T1 - Alcohol withdrawal syndrome

T2 - diagnostic and therapeutic methods

AU - Interdisciplinary Study Group CRARL - SITAC - SIPaD - SITD - SIPDip

AU - Attilia, Fabio

AU - Perciballi, Roberta

AU - Rotondo, Claudia

AU - Capriglione, Ida

AU - Iannuzzi, Silvia

AU - Attilia, Maria Luisa

AU - Coriale, Giovanna

AU - Vitali, Mario

AU - Cereatti, Federica

AU - Fiore, Marco

AU - Ceccanti, Mauro

AU - Laviola, Giovanni

AU - Macri, Simone

AU - Mancinelli, Rosanna

PY - 2018/6/19

Y1 - 2018/6/19

N2 - Alcohol withdrawal syndrome (AWS) is a medical emergency, rare in the general population, but very common among alcoholic individuals, which can lead to severe complications when unrecognized or late treated. It represents a clinical condition which can evolve in few hours or days following an abrupt cessation or reduction of alcohol intake and is characterized by hyperactivity of the autonomic nervous system resulting in the development of typical symptoms. According to DSM-5 criteria, the alcohol withdrawal syndrome is defined as such: if patients present at least two of typical signs and symptoms. The Clinical Institute Withdrawal Assessment of Alcohol Scale, revised version (CIWA-Ar), is the tool for assessing the severity of AWS. The support to patient with AWS includes pharmacological intervention as well as general support, restoration of biochemical imbalances and specific therapy. Regarding the pharmacological treatment, benzodiazepines represent the gold standard, in particular long-acting benzodiazepines, administered with a gradual reduction up to cessation.

AB - Alcohol withdrawal syndrome (AWS) is a medical emergency, rare in the general population, but very common among alcoholic individuals, which can lead to severe complications when unrecognized or late treated. It represents a clinical condition which can evolve in few hours or days following an abrupt cessation or reduction of alcohol intake and is characterized by hyperactivity of the autonomic nervous system resulting in the development of typical symptoms. According to DSM-5 criteria, the alcohol withdrawal syndrome is defined as such: if patients present at least two of typical signs and symptoms. The Clinical Institute Withdrawal Assessment of Alcohol Scale, revised version (CIWA-Ar), is the tool for assessing the severity of AWS. The support to patient with AWS includes pharmacological intervention as well as general support, restoration of biochemical imbalances and specific therapy. Regarding the pharmacological treatment, benzodiazepines represent the gold standard, in particular long-acting benzodiazepines, administered with a gradual reduction up to cessation.

KW - Alcohol Withdrawal Delirium/diagnosis

KW - Alcohol Withdrawal Seizures/drug therapy

KW - Alcoholism/blood

KW - Anticonvulsants/therapeutic use

KW - Antipsychotic Agents/adverse effects

KW - Autonomic Nervous System/physiopathology

KW - Benzodiazepines/administration & dosage

KW - Combined Modality Therapy

KW - Counseling

KW - Delayed Diagnosis

KW - Drug Therapy, Combination

KW - Emergencies

KW - Ethanol/adverse effects

KW - Humans

KW - Kindling, Neurologic

KW - Palliative Care

KW - Severity of Illness Index

KW - Symptom Assessment

KW - Thiamine/therapeutic use

U2 - 10.1708/2925.29413

DO - 10.1708/2925.29413

M3 - Review article

C2 - 29912213

VL - 53

SP - 118

EP - 122

JO - Rivista di Psichiatria

JF - Rivista di Psichiatria

SN - 0035-6484

IS - 3

ER -